Literature DB >> 30298657

Perspectives on acute kidney injury strategy in China.

Youlu Zhao1, Li Yang1.   

Abstract

Acute kidney injury (AKI) has imposed a heavy disease burden in China, with substantial underdiagnosis and undertreatment. The incidence, cause and outcome of patients with AKI vary according to different geographic regions and economic development status; therefore, regional improvement strategies are needed. Defining the etiology of AKI is critical in making the proper therapeutic regimen, and a multidisciplinary cooperative AKI team is essential in order to establish the early diagnosis and proper management of patients with AKI.
© 2018 Asian Pacific Society of Nephrology.

Entities:  

Keywords:  China; acute kidney injury; epidemiology; recognition; treatment

Mesh:

Year:  2018        PMID: 30298657     DOI: 10.1111/nep.13458

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  4 in total

1.  Is acute kidney injury age-dependent in older adults: an observational study in two centers from North China.

Authors:  Libin Xu; Yanhua Wu; Yuanhan Chen; Ruiying Li; Zhiqiang Wang; Zhilian Li; Guoping Liu; Lei Yu; Wei Shi; Xinling Liang
Journal:  BMC Geriatr       Date:  2021-01-06       Impact factor: 3.921

2.  Epidemiology of Sepsis-Associated Acute Kidney Injury in Beijing, China: A Descriptive Analysis.

Authors:  Haiman Wang; Xiaojun Ji; Amanda Ying Wang; Patrick Kevin Wu; Zhuang Liu; Lei Dong; Jingfeng Liu; Meili Duan
Journal:  Int J Gen Med       Date:  2021-09-14

3.  Properdin Deficiency Impairs Phagocytosis and Enhances Injury at Kidney Repair Phase Post Ischemia-Reperfusion.

Authors:  Yuanyuan Wu; Zinah D Zwaini; Nigel J Brunskill; Xinyue Zhang; Hui Wang; Ravinder Chana; Cordula M Stover; Bin Yang
Journal:  Front Immunol       Date:  2021-09-06       Impact factor: 7.561

4.  Clinical features, risk factors, and clinical burden of acute kidney injury in older adults.

Authors:  Yanhua Wu; Wenke Hao; Yuanhan Chen; Shaohua Chen; Wei Liu; Feng Yu; Wenxue Hu; Xinling Liang
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.